DAWN
Day One Biopharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.53
+0.00%Margins
Gross margin
89.1%
EBITDA margin
-78.4%
EBIT margin
-80.8%
Net margin
-67.8%
FCF margin
-68.0%
-24.3%
Return on equity
-21.1%
Return on assets
-28.8%
Return on invested capital
0.31x
Asset turnover
-$103.8M
Cash from operations
$4.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025